The senior notes are due 2029, 2031, 2034 and 2054

Davis Polk advised the representatives of the several underwriters in connection with the SEC-registered offering of $1 billion aggregate principal amount of 5.000% senior notes due 2029, $750 million aggregate principal amount of 5.125% senior notes due 2031, $1.25 billion aggregate principal amount of 5.250% senior notes due 2034 and $1.5 billion aggregate principal amount of 5.600% senior notes due 2054 by the Cigna Group.

Davis Polk is also advising the dealer managers of Cigna’s cash tender offers for (1) any and all of Cigna’s 3.50% senior notes due 2024 and Evernorth Health, Inc.’s 3.50% senior notes due 2024 and (2) up to $1.25 billion of Cigna’s 4.125% senior notes due 2025, Cigna’s 4.500% senior notes due 2026, Evernorth Health, Inc.’s 4.500% senior notes due 2026, Cigna’s 1.250% senior notes due 2026, Cigna’s 3.050% senior notes due 2027, Cigna Holding Company’s 3.050% senior notes due 2027 and Cigna’s 2.400% senior notes due 2030.

Cigna intends to use the net proceeds from the offering to fund the cash tender offers and to pay accrued and unpaid interest and related expenses. Cigna intends to use the net remaining proceeds to fund the repayment of its 0.613% senior notes due 2024 at maturity and for general corporate purposes, which may include repayment of indebtedness and repurchases of shares of its common stock.

Based in Bloomfield, Connecticut, the Cigna Group is a global health company. The Cigna Group includes products and services marketed under Cigna Healthcare, Evernorth Health Services or its subsidiaries.

The Davis Polk corporate team included partner Richard D. Truesdell Jr., counsel Jeffrey S. Ramsay and associate Tomisin Ogunsanya. The tax team included partner Patrick E. Sigmon and associate Dov Sussman. Counsel Charles Shi provided advice on executive compensation. All members of the Davis Polk team are based in the New York office.

Copy link to share post